Shankar Gopi — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Shankar Gopi is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Gopi Shankar is the Chief Development Officer of Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on delivering therapies for rare diseases. In this role, Shankar oversees Larimar's development programs, including the lead candidate CTI-1601 for Friedreich's ataxia, as described in the company's SEC filings.
Role
Insider
Notability
40/100
Board memberships
Larimar Therapeutics, Inc.
Awards & honors
Oversees clinical development programs for CTI-1601
Guides regulatory strategy and clinical operations for Friedreich's ataxia program
Gopi Shankar is the Chief Development Officer of Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on delivering therapies for rare diseases. In this role, Shankar oversees Larimar's development programs, including the lead candidate CTI-1601 for Friedreich's ataxia, as described in the company's SEC filings.…
Where can I see all of Shankar Gopi's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
